Nice find! From the conclusion:
"The manifestations of elevated pro-inflammatory, sustained circulating factors due to the cytokine storm are not just confined to the lungs, with significant damage to the CV system and multi-organ damage and dysfunction. Interventions that target single cytokines (i.e., Tocilizumab targeting IL-6) do not seem efficacious in reducing mortality. Mesenchymal stromal cells owing to their powerful immunomodulatory function can holistically target and suppress the cytokine storm. At the same time, MSC transplantation is safe and has proven effective at activating endogenous repair mechanisms, leading to improved cardiac function, tissue regeneration and decreased fibrosis. Therefore, attenuating persistent organ dysfunction."
Cell Therapy News/Articles, page-7863
-
- There are more pages in this discussion • 10,386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.088(7.03%) |
Mkt cap ! $1.575B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $11.98M | 8.901M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 186925 | $1.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 20532 | 8 |
View Market Depth
| Last trade - 13.15pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |